A. Stacey

Columbus Oncology and Hematology Associates

Papers

1

Total Citations

6

H-Index

1

About

Dr. A. Stacey has made significant contributions to urologic oncology, with a particular focus on comparing surgical outcomes for kidney cancer treatments. Their research centers on the critical evaluation of robotic versus open surgical techniques, specifically for partial nephrectomy—a kidney-sparing procedure for tumor removal. Dr. Stacey’s most cited work, “992 POST OPERATIVE MORBIDITY OF ROBOTIC VERSUS OPEN PARTIAL NEPHRECTOMY: THE IMPACT OF PREOPERATIVE TUMOR CHARACTERISTICS” (2010), with 6 citations, investigates how preoperative tumor features influence postoperative complications between these two approaches. This study provides valuable insights into patient selection and surgical planning, helping to clarify which patients may benefit most from minimally invasive robotic surgery versus traditional open procedures. By examining morbidity outcomes in the context of tumor characteristics, Dr. Stacey’s work aids surgeons in making evidence-based decisions to optimize patient recovery and reduce complications. Their research contributes to the broader effort to refine surgical standards in urologic oncology, offering practical guidance for clinicians treating localized kidney cancer. Dr. Stacey’s findings underscore the importance of personalized surgical approaches, advancing the field toward more tailored, patient-specific care.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
992 POST OPERATIVE MORBIDITY OF ROBOTIC VERSUS OPEN PARTIAL NEPHRECTOMY: THE IMPACT OF PREOPERATIVE TUMOR CHARACTERISTICS
6 citations · 2010
📈 Most Prolific Year: 2010 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Columbus Oncology and Hematology Associates

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago